A comparison of anti-HER2 IgA and IgG1 in vivo efficacy is facilitated by high N-glycan sialylation of the IgA
GJA Rouwendal, MM van der Lee, S Meyer… - MAbs, 2016 - Taylor & Francis
Monomeric IgA has been proposed as an alternative antibody format for cancer therapy.
Here, we present our studies on the production, purification and functional evaluation of anti …
Here, we present our studies on the production, purification and functional evaluation of anti …
Antibody production using a ciliate generates unusual antibody glycoforms displaying enhanced cell-killing activity
J Calow, AJ Behrens, S Mader, U Bockau, WB Struwe… - MAbs, 2016 - Taylor & Francis
Antibody glycosylation is a key parameter in the optimization of antibody therapeutics. Here,
we describe the production of the anti-cancer monoclonal antibody rituximab in the …
we describe the production of the anti-cancer monoclonal antibody rituximab in the …
9th Annual European Antibody Congress, November 11–13, 2013, Geneva, Switzerland
The annual European Antibody Congress (EAC) has traditionally been the key event for
updates on critical scientific advances in the antibody field, and 2013 was no exception …
updates on critical scientific advances in the antibody field, and 2013 was no exception …